Finance

Lists
1733:TPE
Apex Biotechnology Corp
30,55 TWD
+0,33%
(+0,100) 1D
12-окт., 11:00:41 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Open
29,95 TWD
High
30,65 TWD
Low
29,95 TWD
Mkt. cap
3,05 млд
Avg. vol.
112,69 миң
Volume
47,18 миң
Dividend
4,26%
Quarterly dividend
0,32 TWD
Ex-dividend date
2026-ж., 9-июн.
P/E ratio
16,17
52-wk high
38,70 TWD
52-wk low
28,00 TWD
EPS
1,89 TWD
Shares outstanding
99,69 млн
No. of employees
641
Open
29,95 TWD
High
30,65 TWD
Low
29,95 TWD
Mkt. cap
3,05 млд
Avg. vol.
112,69 миң
Volume
47,18 миң
Dividend
4,26%
Quarterly dividend
0,32 TWD
Ex-dividend date
2026-ж., 9-июн.
P/E ratio
16,17
52-wk high
38,70 TWD
52-wk low
28,00 TWD
EPS
1,89 TWD
Shares outstanding
99,69 млн
No. of employees
641
News stories
From web sources and news partners
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorMedical device
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
437,21 млн
438,99 млн
519,72 млн
470,65 млн
Cost of goods sold
330,39 млн
306,63 млн
344,06 млн
312,37 млн
Cost of revenue
330,39 млн
306,63 млн
344,06 млн
312,37 млн
Research and development expenses
35,94 млн
36,02 млн
37,23 млн
49,84 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57,27 млн
62,79 млн
60,29 млн
63,81 млн
Operating expense
98,80 млн
99,12 млн
88,45 млн
113,66 млн
Total operating expenses
429,19 млн
405,75 млн
432,51 млн
426,02 млн
Operating income
8,02 млн
33,24 млн
87,21 млн
44,63 млн
Other non operating income
775,00 миң
894,00 миң
191,00 миң
591,00 миң
EBT including unusual items
29,21 млн
58,17 млн
86,91 млн
44,68 млн
EBT excluding unusual items
34,02 млн
57,52 млн
90,23 млн
41,45 млн
Income tax expense
7,12 млн
7,97 млн
5,54 млн
7,84 млн
Effective tax rate
24,37%
13,70%
6,38%
17,54%
Other operating expenses
-
-
-
-
Net income
22,14 млн
50,08 млн
81,28 млн
36,78 млн
Net profit margin
5,06%
11,41%
15,64%
7,81%
Earnings per share
-
-
-
-
Interest and investment income
139,00 миң
1,49 млн
219,00 миң
4,56 млн
Interest expense
-835,00 миң
-822,00 миң
-829,00 миң
-804,00 миң
Net interest expenses
-696,00 миң
665,00 миң
-610,00 миң
3,75 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
20,24 млн
45,47 млн
99,16 млн
56,25 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору